Geneo®
Geneo is a platform whose gel-capsule applicator releases carbon dioxide while exfoliating and oxygenating the skin, with additional RF and ultrasound treatments.
- Pollogen Ltd. (Lumenis group)
- Israel
Description
Skin softness study
9 out of 10 participants reported softer, younger-looking skin after 6 weekly OxyGeneo treatments — Diaz et al., J Clin Aesthet Dermatol, 2017
FDA clearance for the RF applicator
Since 2024, the Geneo X Elite RF applicator has held FDA 510(k) clearance (K233766) for the non-invasive treatment of mild to moderate facial wrinkles in adults with Fitzpatrick skin phototypes I–IV; a second clearance was obtained in 2025 (K242227)
Pilot study of fine wrinkles
84% of surveyed participants in a pilot study reported a reduction in fine wrinkles after a course of OxyGeneo treatments on the Geneo+ platform, according to the manufacturer (14 people, 12 of whom received 3–6 weekly treatments)
Skin oxygen levels
Skin oxygen levels (TcPO2) increased by approximately 18% 15 minutes after a 10-minute OxyGeneo treatment — a pilot study reported by the manufacturer (11 people)
International availability
Pollogen devices are available in more than 60 countries; Pollogen is the Israeli manufacturer of Geneo, according to the company
Extra
Indications
Dull and tired skin, dryness, uneven tone, fine lines, loss of elasticity, preparation before aesthetic treatments.Rehabilitation
No downtime. Mild warmth or pinkness may appear for 1–2 hours due to increased circulation and oxygenation. Makeup can be applied immediately. Recommended course: 4–6 sessions every 2–3 weeks for cumulative radiance and tone improvement.Contraindications
Active skin inflammation, open wounds, rosacea flare, severe acne, pregnancy (first trimester).Locations
FAQ
Universe of beauty
Entrust your beauty to the professionals at our aesthetic medicine clinic! We offer innovative facial and body care procedures that will highlight your individuality and preserve your youth.
- FAQ for services and prices and Equipment
- Geneo®


